H-NTTGALTTR^-OH

Rif. 3D-PP48340

Informazioni sul prodotto

• Nome: H-NTTGALTTR^-OH

Descrizione

Peptide H-NTTGALTTR^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-NTTGALTTR^-OH include the following: Development and application of a UPLC-MS/MS method for P-glycoprotein quantification in human tumor cells Z Qiu, J Peng, L Mou, X Li, F Meng, P Yu - Journal of Chromatography B, 2018 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1570023217314034 Microvilli morphology can affect efflux active P-glycoprotein in confluent MDCKII-hMDR1-NKI and Caco-2 cell monolayers Z Meng, S Le Marchand, D Agnani, M Szapacs - Drug Metabolism and , 2017 - ASPEThttps://dmd.aspetjournals.org/content/45/2/145.abstract Liquid chromatography/tandem mass spectrometry based targeted proteomics quantification of P-glycoprotein in various biological samples Y Zhang, N Li, PW Brown, JS Ozer - in Mass Spectrometry, 2011 - Wiley Online Libraryhttps://analyticalsciencejournals.onlinelibrary.wiley.com/doi/abs/10.1002/rcm.5026 A study protocol for quantitative targeted absolute proteomics (QTAP) by LC-MS/MS: application for inter-strain differences in protein expression levels of transporters Y Uchida, M Tachikawa, W Obuchi, Y Hoshi - Fluids and Barriers of , 2013 - Springerhttps://link.springer.com/article/10.1186/2045-8118-10-21 and Tetsuya Terasaki1 Y Uchida, M Tachikawa, W Obuchi, Y Hoshi - 2013 - fluidsbarrierscns.biomedcentral.comhttps://fluidsbarrierscns.biomedcentral.com/track/pdf/10.1186/2045-8118-10-21.pdf Comprehensive characterization and optimization of Caco-2 cells enabled the development of a miniaturized 96-well permeability assay X Cai, S Patel, C Huang, A Paiva, Y Sun, G Barker - Xenobiotica, 2022 - Taylor & Francishttps://www.tandfonline.com/doi/abs/10.1080/00498254.2022.2133648 Successful prediction of human fetal exposure to P-glycoprotein substrate drugs using the proteomics-informed relative expression factor approach and PBPK O Anoshchenko , F Storelli , JD Unadkat - Drug Metabolism and Disposition, 2021 - ASPEThttps://dmd.aspetjournals.org/content/49/10/919.abstract Utilizing a Dual Human Transporter MDCKII-MDR1-BCRP Cell Line to Assess Efflux at the Blood Brain Barrier N Colclough, RV Alluri, JW Tucker, E Gozalpour - Drug Metabolism and , 2024 - ASPEThttps://dmd.aspetjournals.org/content/52/2/95.abstract P-gp/ABCB1 exerts differential impacts on brain and fetal exposure to norbuprenorphine MZ Liao, C Gao , LM Shireman, B Phillips - Pharmacological , 2017 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S1043661816312725 Understanding Pregnancy-induced Changes in the Disposition of Norbuprenorphine, Metformin and Glyburide in Mice and Humans for Optimizing Drug Therapy MZ Liao - 2018 - digital.lib.washington.eduhttps://digital.lib.washington.edu/researchworks/handle/1773/41835 Development of a new permeability assay using low-efflux MDCKII cells L Di, C Whitney-Pickett, JP Umland, H Zhang - Journal of , 2011 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022354915318542 Impact of In Vitro Passive Permeability in a P-gp-transfected LLC-PK1 Model on the Prediction of the Rat and Human Unbound Brain-to-Plasma Concentration Ratio J Nicolaaca¯ , H Chapy, E Gillent, K Saunders - Pharmaceutical , 2020 - Springerhttps://link.springer.com/article/10.1007/s11095-020-02867-z Atlas of Membrane Transporter Proteins: Development and Application of a Highly Sensitive Simultaneous LC/MS/MS Method Combined with Novel In-silico Peptide J Kamiie, S Ohtsuki , R Iwase, K Ohmine - Pharmaceutical , 2008 - Springerhttps://link.springer.com/article/10.1007/s11095-008-9532-4 Successful prediction of human steady-state unbound brain-to-plasma concentration ratio of P-gp substrates using the proteomics-informed relative expression F Storelli , O Anoshchenko - Clinical Pharmacology & , 2021 - Wiley Online Libraryhttps://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.2227 Critical issues and optimized practices in quantification of protein abundance level to determine interindividual variability in DMET proteins by LC-MS/MS proteomics DK Bhatt , B Prasad - Clinical Pharmacology & Therapeutics, 2018 - Wiley Online Libraryhttps://ascpt.onlinelibrary.wiley.com/doi/abs/10.1002/cpt.819 LC-MS/MS-based quantification of efflux transporter proteins at the BBB D Gomez-Zepeda , M Taghi, M Smirnova - of Pharmaceutical and , 2019 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708518307131 LC-MS/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins C Gröer, S Bruck, Y Lai , A Paulick, A Busemann - of pharmaceutical and , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0731708513003373 Optimized approaches for quantification of drug transporters in tissues and cells by MRM proteomics B Prasad , JD Unadkat - The AAPS journal, 2014 - Springerhttps://link.springer.com/article/10.1208/s12248-014-9602-y Human hepatic transporter signature peptides for quantitative targeted absolute proteomics: selection, digestion efficiency, and peptide stability A Mori, T Masuda , S Ito, S Ohtsuki - Pharmaceutical Research, 2022 - Springerhttps://link.springer.com/article/10.1007/s11095-022-03387-8

• Marchio: Biosynth